Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-07-18
1985-12-24
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546159, 546162, 560 44, A61K 3147, C07D21516
Patent
active
045606927
ABSTRACT:
Disclosed are compounds of the formula ##STR1## wherein: R.sup.1 and R.sub.2 may be either the same or different and each is hydrogen or lower alkyl;
REFERENCES:
patent: 4299835 (1981-11-01), Champseix et al.
patent: 4402961 (1983-09-01), Dubroeucq et al.
patent: 4450166 (1984-05-01), Clemence et al.
A. Kar, Cinchophen Analogues as Potential CNS Agents, vol. 72, No. 9, 9/83.
Williams, Anxioselective Anxiolytics, 5/83, vol. 26, No. 5.
Arch, Pharm, (Weinheim) 316, 767-772, New Quinolines as Potential CNS Agents.
Biggio and Costa, Benzodiazepine Recognition Site Ligands: Biochemistry and Pharmacology, pp. 129-137.
Field George F.
Zally William J.
Benson Robert
Berch Mark L.
Gould George M.
Hoffmann-La Roche Inc.
Leon Bernard S.
LandOfFree
4-Piperidino-2-phenylquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-Piperidino-2-phenylquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Piperidino-2-phenylquinolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1479525